900175-91-9

Upstream product

• 33174-74-2 2,2 dithiobis(benzonitrile) 
• 23719-80-4 cyclopropylmagnesium bromide 

Downstream Products

• 918810-20-5 2-(Cyclopropylsulfonyl)benzonitrile 
• 900175-92-0 2-(Cyclopropylthio)benzaldehyde 
• 918810-23-8 N-(2-(Cyclopropylsulfonyl)benzyl)-2,2,2-trifluoroacetamide 
• 918810-24-9 N-(2-(Cyclopropylsulfonyl)benzyl)-2,2,2-trifluoro-N-methylacetamide 
• 918810-25-0 N-methyl-(2-(cyclopropylsulfonyl)phenyl)-methaneamine hydrochloride 
• 918810-22-7 2-(cyclopropylsulfonyl)benzylamine hydrochloride salt 

Relevant academic research and scientific papers

BENZAMIDE FACTOR VIIA INHIBITORS USEFUL AS ANTICOAGULANTS

The present invention provides novel benzamide derivatives of Formula (I): or a stereoisomer, tautomer, pharmaceutically acceptable salt, solvate, or prodrug thereof, wherein the variables A, W, Y, Z, R8, and R9 are as defined herein. These compounds are selective inhibitors of factor VIIa which can be used as medicaments.

Phenylglycinamide and pyridylglycinamide derivatives useful as anticoagulants

The present invention provides novel phenylglycinamide derivatives of Formula (I) or (IV): or a stereoisomer, tautomer, pharmaceutically acceptable salt, solvate, or prodrug thereof, wherein the variables W, W1, Y, Z, R7, R8, R9, and R11 are as defined herein. These compounds are selective inhibitors of factor VIIa which can be used as medicaments.

2-(ARYLOXY)ACETAMIDE FACTOR VIIA INHIBITORS USEFUL AS ANTICOAGULANTS

The present invention relates generally to novel 2-(aryloxy)acetamides of Formula (I) or stereoisomers, tautomers, pharmaceutically acceptable salts, solvates, or prodrugs thereof, wherein the variables W, Y, Z, R7, R8, and R9 are as defined herein. These compounds are selective inhibitors of the serine protease coagulation factor VIIa which can be used as medicaments.